Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study.
Tomoya ShukuriKentaro NakaiShigeru TanakaShunsuke YamadaMasanori TokumotoKazuhiko TsuruyaToshiaki NakanoTakanari KitazonoPublished in: Clinical and experimental nephrology (2023)
The present study showed that administering ARB was significantly associated with a lower frequency of bone fracture history.